Having stripped back its workforce, antibiotics biotech Spero Therapeutics continues to strip away its remaining pipeline. | ...

The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the ...

This antibiotic is the first new FDA-approved medication for urinary tract infections in decades, and meets the need for new ...

In seeking new antibiotic sources, researchers have turned to an unlikely source: a whiffy frog known as Odorrana andersonii.

Researchers created safe synthetic antibiotics from frog molecules. These may help fight superbugs in the future.

Engineers have derived potent new antibiotics from a frog's secretions. The new molecules demonstrated capabilities on par with existing last-resort antibiotics, without harming human cells or ...

While most pharma companies have exited the antibiotics area, Japanese drugmaker Shionogi has stuck with it and has just expanded its pipeline with a deal to buy US biotech Qpex Biopharma.

and formerly Eberly Professor of Biotechnology and co-author on the current study—that found cholestyramine, a drug approved by the FDA to treat high cholesterol, could inactivate daptomycin.

GSK is opening the door to a new era in urinary tract infection (UTI) treatment with its Blujepa, the first in a new class of ...

Increased antibiotic use can lead, seemingly paradoxically, to more problematic infections, as the bacteria evolve to resist the treatment.

Frogs may hold the key to fighting dangerous drug-resistant bacteria. These amazing animals have survived for hundreds of ...